An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet

References

• Aoki Y, Matsumoto M, Matsumoto M, Masumura K, Nohmi T. 2019. Mutant frequency is not increased in mice orally exposed to sodium dichromate. Food Saf. 7:2–10.
   Google Scholar
• Aoki Y, Taniguchi Y, Matsumoto M, Matsumoto M, Ohno M, Masumura K, Sasaki S, Tsuzuki T, Yamamoto M, Nohmi T. 2020. Oxidative-stress-driven mutagenesis in the small intestine of the gpt delta mouse induced by oral administration of potassium bromate. Mutat Res. 850–851:503136.
   PubMed Web of Science ®Google Scholar
• Arce GT, Gordon EB, Cohen SM, Singh P. 2010. Genetic toxicology of folpet and captan. Crit Rev Toxicol. 40:546–574.
   PubMed Web of Science ®Google Scholar
• AWWA. 2004. Occurrence survey of boron and hexavalent chromium. Denver (CO): American Water Works Association Research Foundation.
   Google Scholar
• Barker N, van de Wetering M, Clevers H. 2008. The intestinal stem cell. Genes Dev. 22:1856–1864.
   PubMed Web of Science ®Google Scholar
• Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. 2009. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 457:608–611.
   PubMed Web of Science ®Google Scholar
• Becker RA, Ankley GT, Edwards SW, Kennedy SW, Linkov I, Meek B, Sachana M, Segner H, Van Der Burg B, Villeneuve DL, et al. 2015. Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence. Regul Toxicol Pharmacol. 72:514–537.
   PubMed Web of Science ®Google Scholar
• Becker RA, Dellarco V, Seed J, Kronenberg JM, Meek B, Foreman J, Palermo C, Kirman C, Linkov I, Schoeny R, et al. 2017. Quantitative weight of evidence to assess confidence in potential modes of action. Regul Toxicol Pharmacol. 86:205–220.
   PubMed Web of Science ®Google Scholar
• Becker RA, Patlewicz G, Simon TW, Rowlands JC, Budinsky RA. 2015. The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor. Regul Toxicol Pharmacol. 73:172–190.
   PubMed Web of Science ®Google Scholar
• Boobis AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, Schlatter J, Seed J, Vickers C. 2008. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol. 38:87–96.
   PubMed Web of Science ®Google Scholar
• Brooks RA, Gooderham NJ, Edwards RJ, Boobis AR, Winton DJ. 1999. The mutagenicity of benzo[a]pyrene in mouse small intestine. Carcinogenesis. 20:109–114.
   PubMed Web of Science ®Google Scholar
• Brown I. 2013. The pathology of malnutrition and malabsorption. In: Shepherd NA, Warren BF, Williams GT, Greenson JK, Lauwers GY, Novelli MR, editors. Morson and Dawson's gastrointestinal pathology. 5th ed. Chichester (UK): Wiley-Blackwell.
   Google Scholar
• Buttner B, Beyersmann D. 1985. Modification of the erythrocyte anion carrier by chromate. Xenobiotica. 15(8–9):735–741.
   PubMed Web of Science ®Google Scholar
• CDPH. 2011. Chromium-6 in drinking water: an overview of sampling results. Sacramento (CA): California Department of Public Health.
   Google Scholar
• Chandra SA, Nolan MW, Malarkey DE. 2010. Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays. Toxicol Pathol. 38:188–197.
   PubMed Web of Science ®Google Scholar
• Chappell GA, Rager JE, Wolf J, Babic M, LeBlanc KJ, Ring CL, Harris MA, Thompson CM. 2019. Comparison of gene expression responses in the small intestine of mice following exposure to 3 carcinogens using the S1500+ gene set informs a potential common adverse outcome pathway. Toxicol Pathol. 47:851–864.
   PubMed Web of Science ®Google Scholar
• Chidiac P, Goldberg MT. 1987. Lack of induction of nuclear aberrations by captan in mouse duodenum. Environ Mutagen. 9:297–306.
   PubMedGoogle Scholar
• Clay PP. 2004. Evaluation of the in vivo comet assay in the mouse duodenum. Alderley Park, Macclesfield, Cheshire, UK: Central Toxicology Laboratory. Sponsor: Beer Sheva, Israel: Makhteshim Chemical Works, Ltd. Report no. SM1245. September 22, 2004. MRID 47605801. As cited by Arce (2010).
   Google Scholar
• Clewell RA, Thompson CM, Clewell HJ III. 2019. Dose-dependence of chemical carcinogenicity: biological mechanisms for thresholds and implications for risk assessment. Chem Biol Interact. 301:112–127.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Ellwein LB. 1990. Cell proliferation in carcinogenesis. Science. 249:1007–1011.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Gordon EB, Singh P, Arce GT, Nyska A. 2010. Carcinogenic mode of action of folpet in mice and evaluation of its relevance to humans. Crit Rev Toxicol. 40:531–545.
   PubMed Web of Science ®Google Scholar
• Collier ZA, Gust KA, Gonzalez-Morales B, Gong P, Wilbanks MS, Linkov I, Perkins EJ. 2016. A weight of evidence assessment approach for adverse outcome pathways. Regul Toxicol Pharmacol. 75:46–57.
   PubMed Web of Science ®Google Scholar
• Cullen JM, Ward JM, Thompson CM. 2016. Reevaluation and classification of duodenal lesions in B6C3F1 mice and F344 rats from 4 studies of hexavalent chromium in drinking water. Toxicol Pathol. 44:279–289.
   PubMed Web of Science ®Google Scholar
• Dana Devi K, Rozati R, Saleha Banu B, Jamil K, Grover P. 2001. In vivo genotoxic effect of potassium dichromate in mice leukocytes using comet assay. Food Chem Toxicol. 39:859–865.
   PubMed Web of Science ®Google Scholar
• De Flora S, D'Agostini F, Balansky R, Micale R, Baluce B, Izzotti A. 2008. Lack of genotoxic effects in hematopoietic and gastrointestinal cells of mice receiving chromium(VI) with the drinking water. Mutat Res. 659:60–67.
   PubMed Web of Science ®Google Scholar
• De Flora S, Camoirano A, Micale RT, La Maestra S, Savarino V, Zentilin P, Marabotto E, Suh M, Proctor DM. 2016. Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity. Toxicol Appl Pharmacol. 306:113–119.
   PubMed Web of Science ®Google Scholar
• De Flora S, Zanacchi P, Camoirano A, Bennicelli C, Badolati GS. 1984. Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test. Mutat Res Rev Genet Toxicol. 133(3):161–198.
   PubMed Web of Science ®Google Scholar
• DeSesso JM, Lavin AL, Hsia SM, Mavis RD. 2000. Assessment of the carcinogenicity associated with oral exposures to hydrogen peroxide. Food Chem Toxicol. 38:1021–1041.
   PubMed Web of Science ®Google Scholar
• Dickson BC, Streutker CJ, Chetty R. 2006. Coeliac disease: an update for pathologists. J Clin Pathol. 59:1008–1016.
   PubMed Web of Science ®Google Scholar
• Eastmond DA. 2012. Factors influencing mutagenic mode of action determinations of regulatory and advisory agencies. Mutat Res Rev Mutat Res. 751(1):49–63.
   Web of Science ®Google Scholar
• FSCJ. 2017. Risk assessment report captan (pesticides). Food Saf Comm Jpn. 5:61–66.
   Google Scholar
• FSCJ. 2019. Risk assessment report hexavalent chromium (beverages). Food Saf Comm Jpn. 7:56–57.
   Google Scholar
• Gatto NM, Kelsh MA, Mai DH, Suh M, Proctor DM. 2010. Occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract: a meta-analysis. Cancer Epidemiol. 34(4):388–399.
   PubMed Web of Science ®Google Scholar
• Gold LS, Manley NB, Slone TH, Ward JM. 2001. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol Pathol. 29:639–652.
   PubMed Web of Science ®Google Scholar
• Goldberg MT, Chidiac P. 1986. An in vivo assay for small intestine genotoxicity. Mutat Res. 164:209–215.
   PubMedGoogle Scholar
• Gordon E. 2007. Captan: transition from 'B2' to 'not likely'. How pesticide registrants affected the EPA cancer classification update. J Appl Toxicol. 27:519–526.
   PubMed Web of Science ®Google Scholar
• Gordon E, Cohen SM, Singh P. 2012. Folpet-induced short term cytotoxic and proliferative changes in the mouse duodenum. Toxicol Mechan Methods. 22:54–59.
   PubMed Web of Science ®Google Scholar
• Greaves P. 2012. Histopathology of preclinical toxicity studies. 4th ed. London (UK): Elsevier-Academic Press.
   Google Scholar
• Greenfield RE, Ellwein LB, Cohen SM. 1984. A general probabilistic model of carcinogenesis: analysis of experimental urinary bladder cancer. Carcinogenesis. 5:437–445.
   PubMed Web of Science ®Google Scholar
• Groschwitz KR, Hogan SP. 2009. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 124(1):3–20.
   PubMed Web of Science ®Google Scholar
• Gudi R, Krsmanovic L. 2001. Nuclear aberration test in the mouse duo- denum (folpet) and photomicrographs. Rockville (MD): BioReliance. Report no. AA31SK.123005.BTL. MRID 45745105.
   Google Scholar
• Haney J Jr. 2015. Consideration of non-linear, non-threshold and threshold approaches for assessing the carcinogenicity of oral exposure to hexavalent chromium. Regul Toxicol Pharmacol. 73:834–852.
   PubMed Web of Science ®Google Scholar
• Hard GC, Rodgers IS, Baetcke KP, Richards WL, McGaughy RE, Valcovic LR. 1993. Hazard evaluation of chemicals that cause accumulation of alpha 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats. Environ Health Perspect. 99:313–349.
   PubMed Web of Science ®Google Scholar
• Health Canada. 2016. Guidelines for Canadian drinking water quality: guideline technical document – chromium. Ottawa (ON): Health Environment and Consumer Safety Branch, Water and Air Quality Bureau, Health Canada.
   Google Scholar
• Hill AB. 1965. The environment and disease: association or causation? Proc Royal Soc Med. 58(5):295–300.
   PubMedGoogle Scholar
• [IARC] International Agency for Research on Cancer. 1978. Overall evaluations of carcinogenicity: some N-nitroso compounds 17. International Agency for Research on Cancer.
   Google Scholar
• IARC 1987. Overall evaluations of carcinogenicity: an updating of IARC monographs Volumes 1–42. IARC Monographs Supplement 7. International Agency for Research on Cancer.
   Google Scholar
• IARC. 1999a. Some Chemicals that Cause Tumours of the Kidney or Urinary Bladder in Rodents and Some Other Substances 73. International Agency for Research on Cancer.
   Google Scholar
• IARC. 1999b. Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide (Part 1, Part 2, Part 3) 71. International Agency for Research on Cancer.
   Google Scholar
• IARC. 2012a. A review of human carcinogens: arsenic, metals, fibres, and dusts. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 100C. International Agency for Research on Cancer.
   Google Scholar
• IARC. 2012b. Radiation 100D. International Agency for Research on Cancer.
   Google Scholar
• Ito A, Naito M, Naito Y, Watanabe H. 1982. Induction and characterization of gastro-duodenal lesions in mice given continuous oral administration of hydrogen peroxide. Gan. 73:315–322.
   PubMedGoogle Scholar
• Ito A, Watanabe H, Naito M, Naito Y. 1981. Induction of duodenal tumors in mice by oral administration of hydrogen peroxide. Gan. 72:174–175.
   PubMedGoogle Scholar
• Ito A, Watanabe H, Naito M, Naito Y, Kawashima K. 1984. Correlation between induction of duodenal tumor by hydrogen peroxide and catalase activity in mice. Gan. 75:17–21.
   PubMedGoogle Scholar
• JMPR. 1996. Joint FAO/WHO meeting on pesticide residues. Tox Monograph: Folpet.
   Google Scholar
• JMPR. 2004a. Joint FAO/WHO meeting on pesticide residues. Tox Monograph: Folpet. JMPR.
   Google Scholar
• JMPR. 2004b. Joint FAO/WHO meeting on pesticide residues. Tox Monograph: Captan. JMPR.
   Google Scholar
• Johnson GE, Soeteman-Hernandez LG, Gollapudi BB, Bodger OG, Dearfield KL, Heflich RH, Hixon JG, Lovell DP, MacGregor JT, Pottenger LH, et al. 2014. Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment. Environ Mol Mutagen. 55:609–623.
   PubMed Web of Science ®Google Scholar
• Kamboj AK, Oxentenko AS. 2017. Clinical and histologic mimickers of celiac disease. Clin Transl Gastroenterol. 8:e114.
   PubMed Web of Science ®Google Scholar
• Kirkland D, Uno Y, Luijten M, Beevers C, van Benthem J, Burlinson B, Dertinger S, Douglas GR, Hamada S, Horibata K, et al. 2019. In vivo genotoxicity testing strategies: report from the 7th International workshop on genotoxicity testing (IWGT). Mutat Res. 847:403035
   PubMed Web of Science ®Google Scholar
• Kirman CR, Aylward LL, Suh M, Harris MA, Thompson CM, Haws LC, Proctor DM, Lin SS, Parker W, Hays SM. 2013. Physiologically based pharmacokinetic model for humans orally exposed to chromium. Chem Biol Interact. 204:13–27.
   PubMed Web of Science ®Google Scholar
• Kirman CR, Hays SM, Aylward LL, Suh M, Harris MA, Thompson CM, Haws LC, Proctor DM. 2012. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium. Chem Biol Interact. 200:45–64.
   PubMed Web of Science ®Google Scholar
• Kirman CR, Suh M, Hays SM, Gurleyuk H, Gerads R, De Flora S, Parker W, Lin S, Haws LC, Harris MA, et al. 2016. Reduction of hexavalent chromium by fasted and fed human gastric fluid. II. Ex vivo gastric reduction modeling. Toxicol Appl Pharmacol. 306:120–133.
   PubMed Web of Science ®Google Scholar
• Kirman CR, Suh M, Proctor DM, Hays SM. 2017. Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations. Toxicol Appl Pharmacol. 325:9–17.
   PubMed Web of Science ®Google Scholar
• Kopec AK, Kim S, Forgacs AL, Zacharewski TR, Proctor DM, Harris MA, Haws LC, Thompson CM. 2012. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking water. Toxicol Appl Pharmacol. 259:13–26.
   PubMed Web of Science ®Google Scholar
• Kopec AK, Thompson CM, Kim S, Forgacs AL, Zacharewski TR. 2012. Comparative toxicogenomic analysis of oral Cr(VI) exposure effects in rat and mouse small intestinal epithelia. Toxicol Appl Pharmacol. 262:124–138.
   PubMed Web of Science ®Google Scholar
• Lash LH, Hagen TM, Jones DP. 1986. Exogenous glutathione protects intestinal epithelial cells from oxidative injury. Proc Natl Acad Sci USA. 83:4641–4645.
   PubMed Web of Science ®Google Scholar
• MacGregor JT, Frotschl R, White PA, Crump KS, Eastmond DA, Fukushima S, Guerard M, Hayashi M, Soeteman-Hernandez LG, Johnson GE, et al. 2015. IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. Mutat Res Genet Toxicol Environ Mutag. 783:66–78.
   PubMed Web of Science ®Google Scholar
• Martensson J, Jain A, Meister A. 1990. Glutathione is required for intestinal function. Proc Natl Acad Sci USA. 87:1715–1719.
   PubMed Web of Science ®Google Scholar
• McCarroll N, Keshava N, Chen J, Akerman G, Kligerman A, Rinde E. 2010. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI). Environ Mol Mutagen. 51:89–111.
   PubMed Web of Science ®Google Scholar
• McConnell EL, Fadda HM, Basit AW. 2008. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm. 364(2):213–226.
   PubMed Web of Science ®Google Scholar
• McNeill LS, Mclean JE, Parks JL, Edwards MA. 2012. Hexavalent chromium review, part 2: chemistry, occurrence, and treatment. J Am Waterworks Assoc. 104:E395–E405.
   Web of Science ®Google Scholar
• Moffat I, Martinova N, Seidel C, Thompson CM. 2018. Hexavalent chromium in drinking water. J Am Waterworks Assoc. 110:E22–E35.
   Web of Science ®Google Scholar
• Moolgavkar SH, Knudson AG Jr. 1981. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst. 66:1037–1052.
   PubMed Web of Science ®Google Scholar
• Nolte T, Brander-Weber P, Dangler C, Deschl U, Elwell MR, Greaves P, Hailey R, Leach MW, Pandiri AR, Rogers A, et al. 2016. Nonproliferative and proliferative lesions ofthe gastrointestinal tract, pancreas andSalivary glands of the rat and mouse. J Toxicol Pathol. 29:1S–125S.
   PubMed Web of Science ®Google Scholar
• NTP. 2007. National Toxicology Program technical report on the toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice. NTP. NTP Toxicity Report Series Number 72, NIH Publication No. 07-5964.
   Google Scholar
• NTP. 2008. National Toxicology Program technical report on the toxicology and carcinogenesis studies of sodium dichromate dihydrate (CAS No. 7789-12-0) in F344/N rats and B6C3F1 mice (drinking water studies). NTP. NTP TR 546. NIH Publication No. 08-5887.
   Google Scholar
• O'Brien TJ, Ceryak S, Patierno SR. 2003. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res. 533:3–36.
   PubMed Web of Science ®Google Scholar
• O’Brien TJ, Ding H, Suh M, Thompson CM, Parsons BL, Harris MA, Winkelman WA, Wolf JC, Hixon JG, Schwartz AM, et al. 2013. Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water. Mutat Res. 754:15–21.
   PubMed Web of Science ®Google Scholar
• [OECD] Organisation for Economic Co-operation and Development. 2013. Guideline for testing of chemicals. 2013. Test Guideline 488, - Transgenic rodent somatic and germ cell gene mutation assays, adopted July 28. Paris (France): OECD.
   Google Scholar
• OECD. 2018. User’s handbook supplement to the guidance document for developing and assessing AOPs. Paris (France): OECD.
   Google Scholar
• Patlewicz G, Simon TW, Rowlands JC, Budinsky RA, Becker RA. 2015. Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Regul Toxicol Pharmacol. 71:463–477.
   PubMed Web of Science ®Google Scholar
• Perkins EJ, Ashauer R, Burgoon L, Conolly R, Landesmann B, Mackay C, Murphy CA, Pollesch N, Wheeler JR, Zupanic A, et al. 2019. Building and applying quantitative adverse outcome pathway models for chemical hazard and risk assessment. Environ Toxicol Chem. 38:1850–1865.
   PubMed Web of Science ®Google Scholar
• Potten CS, Loeffler M. 1990. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development. 110:1001–1020.
   PubMed Web of Science ®Google Scholar
• Proctor DM, Suh M, Aylward LL, Kirman CR, Harris MA, Thompson CM, Gurleyuk H, Gerads R, Haws LC, Hays SM. 2012. Hexavalent chromium reduction kinetics in rodent stomach contents. Chemosphere. 89:487–493.
   PubMed Web of Science ®Google Scholar
• Rager JE, Ring CL, Fry RC, Suh M, Proctor DM, Haws LC, Harris MA, Thompson CM. 2017. High-throughput screening data interpretation in the context of in vivo transcriptomic responses to oral Cr(VI) exposure. Toxicol Sci. 158:199–212.
   PubMed Web of Science ®Google Scholar
• Salnikow K, Zhitkovich A. 2008. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol. 21(1):28–44.
   PubMed Web of Science ®Google Scholar
• Sasso AF, Schlosser PM. 2015. An evaluation of in vivo models for toxicokinetics of hexavalent chromium in the stomach. Toxicol Appl Pharmacol. 287:293–298.
   PubMed Web of Science ®Google Scholar
• Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Goktuna SI, Ziegler PK, Canli O, Heijmans J, Huels DJ, Moreaux G, et al. 2013. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell. 152:25–38.
   PubMed Web of Science ®Google Scholar
• Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley M, Knaap A, Kroese D, et al.; International Programme on Chemical Safety. 2001. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol. 34:146–152.
   PubMed Web of Science ®Google Scholar
• Stern AH. 2010. A quantitative assessment of the carcinogenicity of hexavalent chromium by the oral route and its relevance to human exposure. Environ Res. 110:798–807.
   PubMed Web of Science ®Google Scholar
• Stout MD, Herbert RA, Kissling GE, Collins BJ, Travlos GS, Witt KL, Melnick RL, Abdo KM, Malarkey DE, Hooth MJ. 2009. Hexavalent chromium is carcinogenic to F344/N rats and B6C3F1 mice after chronic oral exposure. Environ Health Perspect. 117:716–722.
   PubMed Web of Science ®Google Scholar
• Suh M, Wikoff D, Lipworth L, Goodman M, Fitch S, Mittal L, Ring C, Proctor D. 2019. Hexavalent chromium and stomach cancer: a systematic review and meta-analysis. Crit Rev Toxicol. 49:140–159.
   PubMed Web of Science ®Google Scholar
• TCEQ. 2016. Hexavalent chromium oral reference dose: development support document (Final). TCEH.
   Google Scholar
• Thompson CM, Gregory Hixon J, Proctor DM, Haws LC, Suh M, Urban JD, Harris MA. 2012. Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues. Regul Toxicol Pharmacol. 64:68–76.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Haws LC, Harris MA, Gatto NM, Proctor DM. 2011. Application of the U.S. EPA mode of action Framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium. Toxicol Sci. 119:20–40.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Kirman CR, Hays SM, Suh M, Harvey SE, Proctor DM, Rager JE, Haws LC, Harris MA. 2018. Integration of mechanistic and pharmacokinetic information to derive oral reference dose and margin-of-exposure values for hexavalent chromium. J Appl Toxicol. 38:351–365.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Kirman CR, Proctor DM, Haws LC, Suh M, Hays SM, Hixon JG, Harris MA. 2014. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer. J Appl Toxicol. 34:525–536.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Proctor DM, Haws LC, Hebert CD, Grimes SD, Shertzer HG, Kopec AK, Hixon JG, Zacharewski TR, Harris MA. 2011. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium. Toxicol Sci. 123:58–70.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Proctor DM, Suh M, Haws LC, Hebert CD, Mann JF, Shertzer HG, Hixon JG, Harris MA. 2012. Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: implications for carcinogenic modes of action. Toxicol Sci. 125:79–90.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Proctor DM, Suh M, Haws LC, Kirman CR, Harris MA. 2013. Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans. Crit Rev Toxicol. 43:244–274.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Rager JE, Suh M, Ring CL, Proctor DM, Haws LC, Fry RC, Harris MA. 2016. Transcriptomic responses in the oral cavity of F344 rats and B6C3F1 mice following exposure to Cr(VI): implications for risk assessment. Environ Mol Mutagen. 57:706–716.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Seiter J, Chappell MA, Tappero RV, Proctor DM, Suh M, Wolf JC, Haws LC, Vitale R, Mittal L, et al. 2015. Synchrotron-based imaging of chromium and gamma-H2AX immunostaining in the duodenum following repeated exposure to cr(VI) in drinking water. Toxicol Sci. 143:16–25.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Suh M, Proctor DM, Haws LC, Harris MA. 2017. Ten factors for considering the mode of action of Cr(VI)-induced gastrointestinal tumors in rodents. Mutat Res. 823:45–57.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Wolf JC, Elbekai RH, Paranjpe MG, Seiter JM, Chappell MA, Tappero RV, Suh M, Proctor DM, Bichteler A, et al. 2015. Duodenal crypt health following exposure to Cr(VI): micronucleus scoring, gamma-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy. Mutat Res Genet Toxicol Environ Mutag. 789–790:61–66.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Wolf JC, McCoy A, Suh M, Proctor DM, Kirman CR, Haws LC, Harris MA. 2017. Comparison of toxicity and recovery in the duodenum of B6C3F1 mice following treatment with intestinal carcinogens captan, folpet, and hexavalent chromium. Toxicol Pathol. 45:1091–1101.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Young RR, Dinesdurage H, Suh M, Harris MA, Rohr AC, Proctor DM. 2017. Assessment of the mutagenic potential of hexavalent chromium in the duodenum of big blue(R) rats. Toxicol Appl Pharmacol. 330:48–52.
   PubMed Web of Science ®Google Scholar
• Thompson CM, Young RR, Suh M, Dinesdurage HR, Elbekai RH, Harris MA, Rohr AC, Proctor DM. 2015. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue((R)) transgenic F344 rats. Environ Mol Mutagen. 56:621–628.
   PubMed Web of Science ®Google Scholar
• Tomasetti C, Marchionni L, Nowak MA, Parmigiani G, Vogelstein B. 2015. Only three driver gene mutations are required for the development of lung and colorectal cancers. Proc Natl Acad Sci USA. 112:118–123.
   PubMed Web of Science ®Google Scholar
• Tomasetti C, Vogelstein B. 2015. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 347:78–81.
   PubMed Web of Science ®Google Scholar
• Treuting PM, Arends MJ, Dintzis SM. 2018. Upper gastrointestinal tract. In: Treuting PM, Dintzis SM, Montine KS, editors. Comparative anatomy and histology. London (UK): Academic Press; p. 191–211.
   Google Scholar
• U.S. EPA. 1995. Science assessment of captan. [Memorandum dated 1995 Feb 21]. Washington (DC): U.S. Environmental Protection Agency.
   Google Scholar
• U.S. EPA. 1999. Reregistration eligibility decision (RED). Folpet. Washington (DC): U.S. Environmental Protection Agency. EPA/738/R-99/011.
   Google Scholar
• U.S. EPA. 2004. Captan; Cancer reclassification; Amendment of reregistration eligibility decision; Notice of availability. Fed Regist. 69:68357–68360.
   Google Scholar
• U.S. EPA. 2005. Guidelines for carcinogen risk assessment. Risk Assessment Forum. Washington (DC): U.S. Environmental Protection Agency. EPA/630/P-03/001F.
   Google Scholar
• U.S. EPA. 2010. Toxicological review of hexavalent chromium in support of summary information on the integrated risk information system (IRIS). External Review DRAFT. Washington (DC): U.S. Environmental Protection Agency.
   Google Scholar
• U.S. EPA. 2012. Folpet: human health risk scoping document in support of registration review. [Memorandum dated 2012 Nov 28]. Washington (DC): U.S. Environmental Protection Agency.
   Google Scholar
• U.S. EPA. 2017. Data summary of the third unregulated contaminant monitoring rule (UCMR3). Washington (DC): U.S. Environmental Protection Agency. EPA 815‐S‐17‐001.
   Google Scholar
• U.S. EPA. 2019. Exposure Factors Handbook 2011 Edition, Chapter 3: ingestion of water and other select liquids (February 2019 Update). Washington (DC): U.S. Environmental Protection Agency. EPA/600/R-18/259F.
   Google Scholar
• Uzal FA, Plattner BL, Hostetter JM. 2016. Alimentary system. In: Maxie MG, editor. Pathology of domestic animals. 6th ed. St. Louis (MO): Elsevier.
   Google Scholar
• van der Flier LG, Clevers H. 2009. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 71:241–260.
   PubMed Web of Science ®Google Scholar
• Weiner ML, Freeman C, Trochimowicz H, de Gerlache J, Jacobi S, Malinverno G, Mayr W, Regnier JF. 2000. 13-week drinking water toxicity study of hydrogen peroxide with 6-week recovery period in catalase-deficient mice. Food Chem Toxicol. 38:607–615.
   PubMed Web of Science ®Google Scholar
• [WHO] World Health Organization. 2019. Chromium in drinking water: draft background document for development of WHO guidelines for drinking-water quality. WHO.
   Google Scholar
• Wieczorek M, Szafrańska PA, Labecka AM, Lázaro J, Konarzewski M. 2015. Effect of the abrasive properties of sedges on the intestinal absorptive surface and resting metabolic rate of root voles. J Exp Biol. 218:309–315.
   PubMed Web of Science ®Google Scholar
• Wilkinson CF, Arce G, Gordon EB. 2004. Scientific analysis of the data relating to the reclassification of captan under EPA’s new guidelines for carcinogen risk assessment. Captan Task Force. CTF 0104.
   Google Scholar
• Williams JM, Duckworth CA, Burkitt MD, Watson AJM, Campbell BJ, Pritchard DM. 2015. Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip. Vet Pathol. 52(3):445–455.
   PubMed Web of Science ®Google Scholar
• Witt KL, Stout MD, Herbert RA, Travlos GS, Kissling GE, Collins BJ, Hooth MJ. 2013. Mechanistic insights from the NTP studies of chromium. Toxicol Pathol. 41:326–342.
   PubMed Web of Science ®Google Scholar
• Wong ZA, Chang HM. 1985. The comparative metabolism of captan in the rat and mouse. Richmond (CA): Chevron Chemical Company. [Dated 1985 Nov 14]. Unpublished study No. SOCAL 1992, S-2163. Accession No. 262633.
   Google Scholar
• Wood CE, Hukkanen RR, Sura R, Jacobson-Kram D, Nolte T, Odin M, Cohen SM. 2015. Scientific and Regulatory Policy Committee (SRPC) review: interpretation and use of cell proliferation data in cancer risk assessment. Toxicol Pathol. 43:760–775.
   PubMed Web of Science ®Google Scholar
• Zainab JM, Jihad AA, Assel KH. 2016. Toxicopathological effects of sodium dichromate (chromium CrVI) on small intestine of laboratory albino rats (Rattus norvegicus). Al-Qadisiyah J Vet Med Sci. 15:5.
   Google Scholar
• Zhitkovich A. 2011. Chromium in drinking water: sources, metabolism, and cancer risks. Chem Res Toxicol. 24:1617–1629.
   PubMed Web of Science ®Google Scholar
• Zou WY, Blutt SE, Zeng XL, Chen MS, Lo YH, Castillo-Azofeifa D, Klein OD, Shroyer NF, Donowitz M, Estes MK. 2018. Epithelial WNT liagnds are essential drivers of intestinal stem cell activation. Cell Rep. 22:1003–1015.
   PubMed Web of Science ®Google Scholar